Take 1 tablet daily with a meal or as directed by your healthcare provider
(2023) 19:e1011090
And we dont know the long-term consequences these drugs might have for healthy-weight people who take them for weight loss
GLP-1 Drugs & Malnutrition: Why Litigation Is Coming Introduction The rise of GLP-1 receptor agonists (Ozempic, Wegovy, Saxenda, Mounjaro) has transformed treatment for obesity and diabetes
broad cytoprotective and healing activity across tissues Semaglutide : GLP-1 receptor agonist activating Gs-cAMP-PKA signaling for glucose- dependent insulin secretion, central appetite suppression, and delayed gastric emptying
Masi F, Scheggi S, Mangiavacchi S, Tolu P, Tagliamonte A, De Montis MG (2001)